Developer docs
API playgroundTry for free, no card

Search company profiles

Diagnóstica Longwood

Full company profile

uuid000humv

Namestring
Diagnóstica Longwood
Legal namestring
DIAGNOSTICA LONGWOOD S.L.U.
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Diagnóstica Longwood is a privately held Spanish distributor (DIAGNOSTICA LONGWOOD S.L.U.) founded in 1992 and headquartered in Zaragoza, specializing in in vitro diagnostic (IVD) products for molecular biology. The company does not develop proprietary technology; instead it curates, distributes, and provides technical support for a portfolio of more than 40 international manufacturers spanning next-generation sequencing (Illumina, SOPHiA Genetics, Agilent, Twist Bioscience), qPCR and fragment analysis, spatial biology (Standard Biotools), HLA typing (GenDx, Inno-train), reproductive genetics (Yikon Genomics), transplantation diagnostics (CareDx), microbiology (Bruker, Certest, Arrow Diagnostics, Qiagen), and bioinformatics/clinical interpretation software (SOPHiA DDM GEN2, VarSome Clinical, SeqOne). Its customer base consists of diagnostic laboratories and research institutions in Spain, with secondary extension into Portugal and Uruguay; use cases include molecular diagnostics, oncology, hereditary cancer, reproductive genetics, microbiology, and immunology.

The business model is one-time resale of reagents, kits, instruments, and software licenses, augmented by deep technical services — expert scientific advisors provide assay setup, protocol development, workflow optimization, and ongoing consultation. The company operates owned inventory in Spain with dedicated warehouse and laboratory facilities in Zaragoza, plus sales offices in Madrid and Barcelona. Go-to-market is sales-led, combining direct field engagement with participation in major scientific congresses (SEHH-SETH, SEIMC, SEI, ECCMID), sponsored events, and educational webinars. Pricing is not publicly disclosed and is negotiated on a case-by-case basis typical of B2B specialized laboratory supply. The company holds ISO 9001 quality management certification and ENS (Spanish National Security Framework) cybersecurity certification under Royal Decree 311/2022.

Strategically, the company has evolved from a pure Spain-focused distributor into a multi-country Iberian/LATAM platform with regional headquarters in Montevideo (Uruguay) and Lisbon (Portugal). The two flagship analytical platforms — SOPHiA DDM GEN2 (AI-powered clinical genomics) and VarSome Clinical (CE-IVDR NGS interpretation) — anchor a positioning that emphasizes complete end-to-end workflows from sample preparation through clinical interpretation, while the underlying AI/ML capability resides with the OEMs rather than with Diagnóstica Longwood itself.

Short descriptiontext

Diagnóstica Longwood is a privately held Spanish distributor founded in 1992, headquartered in Zaragoza, that resells in vitro diagnostic products from 40+ international manufacturers to diagnostic and research laboratories in Spain, Portugal, and Uruguay, providing technical consultation and workflow support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersZaragoza, Spain
HQ citystring
Zaragoza
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics, in vitro diagnostics, clinical genomics, diagnostic distribution, NGS solutions
Industry2 codes
1Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
CodeHLAHAAADPrimaryYes
2Microbiology & Infectious Disease Diagnostics (Culture/ID/AST)
CodeHLAHAAACPrimaryNo
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In Vitro Diagnostics Distribution
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Distribution of In Vitro Diagnostic Products
TypeOne Time License
Description

Diagnóstica Longwood generates revenue through the distribution and resale of molecular biology diagnostic products, reagents, and equipment from international manufacturers to diagnostic and research laboratories in Spain and surrounding regions. The company maintains its own inventory in Spain and provides logistics, technical support, and consulting services alongside product sales.

dlongwood.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Diagnóstica Longwood is a specialized distributor of in vitro diagnostic products and solutions for molecular biology. The company curates and distributes products from over 40 international manufacturers spanning NGS, qPCR, fragment analysis, spatial biology, and bioinformatics software. It provides expert scientific consultation, assay setup, protocol development, workflow optimization, and logistics services to clinical diagnostic and research laboratories in Spain and selected international markets.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Diagnóstica Longwood is a distributor of in vitro diagnostic products for molecular biology, representing a multi-brand portfolio of technologies rather than a single unified product. The portfolio is organized around two core analytical platforms — SOPHiA DDM GEN2 for AI-powered clinical genomics and VarSome Clinical for CE-IVDR NGS data interpretation — supplemented by specialized products across several domains. In reproductive genetics, the company offers preimplantation genetic testing solutions including KaryoSeq (integrated PGT-M/PGT-SR/PGT-A), MaReCs (carrier status determination), and PGT-SR (structural rearrangement analysis) from Yikon Genomics. Hereditary cancer testing includes HBOC, BRCA, and LynchFAP panels from Devyser and SOPHiA GENETICS. The portfolio also spans solid tumor profiling (HederaDx panels), microbiology (Arrow Diagnostics, Certest), whole genome/exome sequencing (Illumina, Twist), and HLA typing (inno-train). The company's offering emphasizes complete end-to-end workflows spanning from sample preparation through data analysis, with particular strength in NGS-based solutions.

Product and service10 records
1SOPHiA DDM GEN2
CategoryBioinformatics software
Description

Analytical platform for clinical genomics that uses artificial intelligence to perform quality control, alignment, variant detection, annotation, and pre-classification into pathogenicity categories. Designed for clinical diagnostic laboratories conducting oncology, rare disease, and hereditary disorder testing.

2VarSome Clinical
CategoryBioinformatics software
Description

CE-IVDR certified platform for clinical interpretation of NGS data. Performs calling, annotation, classification and prioritisation of germline and somatic variants, integrating curated evidence from databases such as ClinVar, gnomAD, DECIPHER, OncoKB, CKB, and COSMIC to support diagnostic decisions.

3KaryoSeq
CategoryReproductive genetics
Description

Next-generation sequencing-based solution for preimplantation genetic testing that enables PGT-M, PGT-SR, and PGT-A within a single workflow. Based on MARSALA principle with whole-genome amplification of single cells using NGS technology. For IVF and reproductive genetics laboratories.

4MaReCs (Mapping allele with resolved carrier state test)
CategoryReproductive genetics
Description

PGT-SR technology that identifies aneuploid or euploid embryos and analyses translocation breakpoints and SNP linkage to differentiate carrier from non-carrier euploid embryos. Combines ChromSwift technology with NGS sequencing for reproductive genetics laboratories.

5Hedera Profiling 1 FFPE Test Panel (HP1)
CategoryOncology diagnostics
Description

In-house targeted enrichment NGS panel for pan-cancer solid tumor profiling. Analyses 115 genes (79 with complete CDS) with ESCAT I, II and III clinical evidence, detecting SNVs, Indels, CNVs, fusions, structural variants, and MSI. For FFPE tissue samples.

6Devyser BRCA NGS
CategoryHereditary cancer diagnostics
Description

Fast and robust NGS solution designed for detection of genetic variants in the BRCA1 and BRCA2 genes with comprehensive and uniform coverage of all coding exons and exon/intron junctions. For hereditary cancer testing laboratories.

7Devyser LynchFAP
CategoryHereditary cancer diagnostics
Description

Targeted NGS solution for analysis of germline variants associated with hereditary colorectal cancer syndromes including Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP).

8HLA-SuBiTo NGStype
CategoryTransplantation diagnostics
Description

High-resolution NGS-based HLA typing system supporting multiple sequencing platforms using a long-range PCR approach for simultaneous analysis of up to 11 HLA loci. For HLA typing and transplantation diagnostics laboratories.

9OncoDEEP
CategoryOncology diagnostics
Description

In vitro diagnostic solution designed by oncology experts for molecular characterization of solid tumors via NGS. For clinical oncology and pathology laboratories.

10VIASURE 16S V1-V4 NGS Solution
CategoryMicrobiology diagnostics
Description

NGS solution for library preparation aimed at simultaneous identification and profiling of microbial species through analysis of the variable regions V1-V4 of the 16S rRNA gene. Product for research use only.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Illumina is a major brand distributed by Diagnóstica Longwood, providing next-generation sequencing solutions, instruments, and reagents for genomic analysis applications including infectious disease surveillance, microbial profiling, and clinical genomics.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

SOPHIA Genetics provides the SOPHiA DDM platform, an AI-powered clinical genomics analytics platform for variant detection, annotation, and interpretation distributed by Diagnóstica Longwood.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Yikon Genomics products include KaryoSeq for preimplantation genetic testing (PGT-M, PGT-SR, PGT-A), MaReCs technology, and reproductive health solutions distributed by Diagnóstica Longwood.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Agilent provides SureSelect capture-based enrichment solutions for exome and targeted sequencing, distributed by Diagnóstica Longwood.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

CareDx specializes in transplantation diagnostics including post-transplant monitoring solutions for chimerism and donor-derived cell-free DNA (dd-cfDNA) testing.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Werfen provides diagnostic solutions for immunohematology and blood safety, distributed by Diagnóstica Longwood in the Spanish market.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Varsome provides CE-IVDR clinical interpretation platforms for NGS data analysis, including VarSome Clinical for germline and somatic variant interpretation.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Twist Bioscience provides synthetic DNA, precision exome solutions, methylation detection systems, and target enrichment solutions for NGS applications.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Arrow Diagnostics provides molecular diagnostic kits for microbiology including HIV-1, HCV, HBV solutions and microbiome profiling using NGS technology.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

GenDx provides NGS solutions for HLA typing, chimerism monitoring, and immunology testing including the NGSengine software platform.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Inno-train provides HLA typing solutions including the HLA-SuBiTo NGStype system for high-resolution NGS-based HLA sequencing.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Devyser provides targeted NGS solutions for hereditary cancer including BRCA, HBOC, LynchFAP panels, and thalassemia testing.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

HederaDx provides targeted NGS panels for solid tumor profiling including FFPE and liquid biopsy applications for pan-cancer analysis.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Certest provides molecular diagnostic solutions including the VIASURE 16S V1-V4 NGS solution for microbial identification and profiling.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Bruker provides MALDI-TOF mass spectrometry systems for microbial identification in clinical microbiology laboratories.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Standard Biotools provides spatial biology solutions including GeoMX and CosMx platforms for spatial transcriptomics and proteomics analysis.

Strategic tierStandardTypeChannel Partner/ Reseller/ Distributor
Description

Qiagen provides sample and assay technologies for molecular diagnostics including automated extraction and PCR solutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Spain's largest medical technology and IVD distributor, headquartered in Barcelona with nationwide coverage. Direct competitor in Spanish molecular diagnostics distribution, addressing the same diagnostic and research laboratory customers with comparable multi-brand distribution models.

TypeBroad incumbent
Description

Iberian-headquartered IVD and medical device company with global reach, including the Izasa Scientific distribution arm. Both a partner of Diagnóstica Longwood and a broader incumbent competitor in Spanish IVD distribution, with significantly greater scale and product breadth.

TypeBroad incumbent
Description

Global leader in microbiology diagnostics whose MALDI-TOF and molecular products are distributed by Diagnóstica Longwood in Spain. A broader incumbent competing across the same molecular and infectious disease diagnostic categories.

TypeBroad incumbent
Description

One of the largest IVD manufacturers globally, with deep penetration in Spanish hospital and reference laboratories. Represents both a potential partner and the principal disintermediation risk for distributors operating in molecular diagnostics.

TypeBroad incumbent
Description

Sample preparation and molecular diagnostics manufacturer whose products are distributed by Diagnóstica Longwood. A global incumbent in the same molecular biology workflow categories the company serves in Iberia.

TypeBroad incumbent
Description

Molecular diagnostics manufacturer with strong presence in women's health, virology, and transplant monitoring. Overlaps with Diagnóstica Longwood's infectious disease and transplantation diagnostic product lines in Spain.

TypeBroad incumbent
Description

Molecular diagnostics leader behind the GeneXpert platform. A direct competitive threat in molecular infectious disease diagnostics across Spanish hospital networks.

TypeBroad incumbent
Description

Global IVD incumbent with broad molecular diagnostics and immunoassay offerings, widely distributed in Spanish reference laboratories. Competes with Diagnóstica Longwood for the same institutional customers.

TypeRegional player
Description

Spanish genetics and molecular diagnostics laboratory services provider based in Valencia. Regional competitor in hereditary cancer, reproductive genetics, and NGS-based testing in Spain.

TypeDirect peer
Description

Spanish IVD manufacturer and distributor specializing in molecular biology and infectious disease diagnostics. A direct Spanish competitor operating in overlapping molecular diagnostic product categories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diagnóstica Longwood

In Vitro Diagnostics Distributiondlongwood.com

Diagnóstica Longwood is a privately held Spanish distributor founded in 1992, headquartered in Zaragoza, that resells in vitro diagnostic products from 40+ international manufacturers to diagnostic and research laboratories in Spain, Portugal, and Uruguay, providing technical consultation and workflow support.

What Diagnóstica Longwood does

Diagnóstica Longwood is a privately held Spanish distributor (DIAGNOSTICA LONGWOOD S.L.U.) founded in 1992 and headquartered in Zaragoza, specializing in in vitro diagnostic (IVD) products for molecular biology. The company does not develop proprietary technology; instead it curates, distributes, and provides technical support for a portfolio of more than 40 international manufacturers spanning next-generation sequencing (Illumina, SOPHiA Genetics, Agilent, Twist Bioscience), qPCR and fragment analysis, spatial biology (Standard Biotools), HLA typing (GenDx, Inno-train), reproductive genetics (Yikon Genomics), transplantation diagnostics (CareDx), microbiology (Bruker, Certest, Arrow Diagnostics, Qiagen), and bioinformatics/clinical interpretation software (SOPHiA DDM GEN2, VarSome Clinical, SeqOne). Its customer base consists of diagnostic laboratories and research institutions in Spain, with secondary extension into Portugal and Uruguay; use cases include molecular diagnostics, oncology, hereditary cancer, reproductive genetics, microbiology, and immunology.

The business model is one-time resale of reagents, kits, instruments, and software licenses, augmented by deep technical services — expert scientific advisors provide assay setup, protocol development, workflow optimization, and ongoing consultation. The company operates owned inventory in Spain with dedicated warehouse and laboratory facilities in Zaragoza, plus sales offices in Madrid and Barcelona. Go-to-market is sales-led, combining direct field engagement with participation in major scientific congresses (SEHH-SETH, SEIMC, SEI, ECCMID), sponsored events, and educational webinars. Pricing is not publicly disclosed and is negotiated on a case-by-case basis typical of B2B specialized laboratory supply. The company holds ISO 9001 quality management certification and ENS (Spanish National Security Framework) cybersecurity certification under Royal Decree 311/2022.

Strategically, the company has evolved from a pure Spain-focused distributor into a multi-country Iberian/LATAM platform with regional headquarters in Montevideo (Uruguay) and Lisbon (Portugal). The two flagship analytical platforms — SOPHiA DDM GEN2 (AI-powered clinical genomics) and VarSome Clinical (CE-IVDR NGS interpretation) — anchor a positioning that emphasizes complete end-to-end workflows from sample preparation through clinical interpretation, while the underlying AI/ML capability resides with the OEMs rather than with Diagnóstica Longwood itself.

Diagnóstica Longwood firmographics

Firmographics
Name
Diagnóstica Longwood
Legal name
DIAGNOSTICA LONGWOOD S.L.U.
Website
https://www.dlongwood.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
51–100 employees
Short description
Diagnóstica Longwood is a privately held Spanish distributor founded in 1992, headquartered in Zaragoza, that resells in vitro diagnostic products from 40+ international manufacturers to diagnostic and research laboratories in Spain, Portugal, and Uruguay, providing technical consultation and workflow support.
Ownership category
akta.pro rank

Diagnóstica Longwood industry classification

Industry
Product category
In Vitro Diagnostics Distribution
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
akta.pro secondary industry
Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)

Keywords

  • Molecular diagnostics
  • In vitro diagnostics
  • Clinical genomics
  • Diagnostic distribution
  • NGS solutions

Where Diagnóstica Longwood is headquartered

Location

Headquarters

HQ city
Zaragoza
HQ country
Spain
HQ region
Europe

Offices7 records

Markets served

Diagnóstica Longwood business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

  1. Distribution of In Vitro Diagnostic Products: Diagnóstica Longwood generates revenue through the distribution and resale of molecular biology diagnostic products, reagents, and equipment from international manufacturers to diagnostic and research laboratories in Spain and surrounding regions. The company maintains its own inventory in Spain and provides logistics, technical support, and consulting services alongside product sales.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Diagnóstica Longwood product offering

Product offering

Core offering

Diagnóstica Longwood is a specialized distributor of in vitro diagnostic products and solutions for molecular biology. The company curates and distributes products from over 40 international manufacturers spanning NGS, qPCR, fragment analysis, spatial biology, and bioinformatics software. It provides expert scientific consultation, assay setup, protocol development, workflow optimization, and logistics services to clinical diagnostic and research laboratories in Spain and selected international markets.

Product overview

Diagnóstica Longwood is a distributor of in vitro diagnostic products for molecular biology, representing a multi-brand portfolio of technologies rather than a single unified product. The portfolio is organized around two core analytical platforms — SOPHiA DDM GEN2 for AI-powered clinical genomics and VarSome Clinical for CE-IVDR NGS data interpretation — supplemented by specialized products across several domains. In reproductive genetics, the company offers preimplantation genetic testing solutions including KaryoSeq (integrated PGT-M/PGT-SR/PGT-A), MaReCs (carrier status determination), and PGT-SR (structural rearrangement analysis) from Yikon Genomics. Hereditary cancer testing includes HBOC, BRCA, and LynchFAP panels from Devyser and SOPHiA GENETICS. The portfolio also spans solid tumor profiling (HederaDx panels), microbiology (Arrow Diagnostics, Certest), whole genome/exome sequencing (Illumina, Twist), and HLA typing (inno-train). The company's offering emphasizes complete end-to-end workflows spanning from sample preparation through data analysis, with particular strength in NGS-based solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • SOPHiA DDM GEN2 Analytical platform for clinical genomics that uses artificial intelligence to perform quality control, alignment, variant detection, annotation, and pre-classification into pathogenicity categories. Designed for clinical diagnostic laboratories conducting oncology, rare disease, and hereditary disorder testing.
  • VarSome Clinical CE-IVDR certified platform for clinical interpretation of NGS data. Performs calling, annotation, classification and prioritisation of germline and somatic variants, integrating curated evidence from databases such as ClinVar, gnomAD, DECIPHER, OncoKB, CKB, and COSMIC to support diagnostic decisions.
  • KaryoSeq Next-generation sequencing-based solution for preimplantation genetic testing that enables PGT-M, PGT-SR, and PGT-A within a single workflow. Based on MARSALA principle with whole-genome amplification of single cells using NGS technology. For IVF and reproductive genetics laboratories.
  • MaReCs (Mapping allele with resolved carrier state test) PGT-SR technology that identifies aneuploid or euploid embryos and analyses translocation breakpoints and SNP linkage to differentiate carrier from non-carrier euploid embryos. Combines ChromSwift technology with NGS sequencing for reproductive genetics laboratories.
  • Hedera Profiling 1 FFPE Test Panel (HP1) In-house targeted enrichment NGS panel for pan-cancer solid tumor profiling. Analyses 115 genes (79 with complete CDS) with ESCAT I, II and III clinical evidence, detecting SNVs, Indels, CNVs, fusions, structural variants, and MSI. For FFPE tissue samples.
  • Devyser BRCA NGS Fast and robust NGS solution designed for detection of genetic variants in the BRCA1 and BRCA2 genes with comprehensive and uniform coverage of all coding exons and exon/intron junctions. For hereditary cancer testing laboratories.
  • Devyser LynchFAP Targeted NGS solution for analysis of germline variants associated with hereditary colorectal cancer syndromes including Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP).
  • HLA-SuBiTo NGStype High-resolution NGS-based HLA typing system supporting multiple sequencing platforms using a long-range PCR approach for simultaneous analysis of up to 11 HLA loci. For HLA typing and transplantation diagnostics laboratories.
  • OncoDEEP In vitro diagnostic solution designed by oncology experts for molecular characterization of solid tumors via NGS. For clinical oncology and pathology laboratories.
  • VIASURE 16S V1-V4 NGS Solution NGS solution for library preparation aimed at simultaneous identification and profiling of microbial species through analysis of the variable regions V1-V4 of the 16S rRNA gene. Product for research use only.

Companies that use Diagnóstica Longwood

Customer profile

Segments2 records

Ideal customer profiles2 records

Diagnóstica Longwood technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Diagnóstica Longwood partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core and standard.

  • IlluminacoreChannel Partner/ Reseller/ DistributorIllumina is a major brand distributed by Diagnóstica Longwood, providing next-generation sequencing solutions, instruments, and reagents for genomic analysis applications including infectious disease surveillance, microbial profiling, and clinical genomics.
  • SOPHIA GeneticscoreChannel Partner/ Reseller/ DistributorSOPHIA Genetics provides the SOPHiA DDM platform, an AI-powered clinical genomics analytics platform for variant detection, annotation, and interpretation distributed by Diagnóstica Longwood.
  • Yikon GenomicscoreChannel Partner/ Reseller/ DistributorYikon Genomics products include KaryoSeq for preimplantation genetic testing (PGT-M, PGT-SR, PGT-A), MaReCs technology, and reproductive health solutions distributed by Diagnóstica Longwood.
  • AgilentcoreChannel Partner/ Reseller/ DistributorAgilent provides SureSelect capture-based enrichment solutions for exome and targeted sequencing, distributed by Diagnóstica Longwood.
  • CareDxcoreChannel Partner/ Reseller/ DistributorCareDx specializes in transplantation diagnostics including post-transplant monitoring solutions for chimerism and donor-derived cell-free DNA (dd-cfDNA) testing.
  • WerfencoreChannel Partner/ Reseller/ DistributorWerfen provides diagnostic solutions for immunohematology and blood safety, distributed by Diagnóstica Longwood in the Spanish market.
  • VarsomecoreChannel Partner/ Reseller/ DistributorVarsome provides CE-IVDR clinical interpretation platforms for NGS data analysis, including VarSome Clinical for germline and somatic variant interpretation.
  • Twist BiosciencecoreChannel Partner/ Reseller/ DistributorTwist Bioscience provides synthetic DNA, precision exome solutions, methylation detection systems, and target enrichment solutions for NGS applications.
  • Arrow DiagnosticsstandardChannel Partner/ Reseller/ DistributorArrow Diagnostics provides molecular diagnostic kits for microbiology including HIV-1, HCV, HBV solutions and microbiome profiling using NGS technology.
  • GenDxstandardChannel Partner/ Reseller/ DistributorGenDx provides NGS solutions for HLA typing, chimerism monitoring, and immunology testing including the NGSengine software platform.
  • Inno-train DiagnostikstandardChannel Partner/ Reseller/ DistributorInno-train provides HLA typing solutions including the HLA-SuBiTo NGStype system for high-resolution NGS-based HLA sequencing.
  • DevyserstandardChannel Partner/ Reseller/ DistributorDevyser provides targeted NGS solutions for hereditary cancer including BRCA, HBOC, LynchFAP panels, and thalassemia testing.
  • HederaDxstandardChannel Partner/ Reseller/ DistributorHederaDx provides targeted NGS panels for solid tumor profiling including FFPE and liquid biopsy applications for pan-cancer analysis.
  • CerteststandardChannel Partner/ Reseller/ DistributorCertest provides molecular diagnostic solutions including the VIASURE 16S V1-V4 NGS solution for microbial identification and profiling.
  • BrukerstandardChannel Partner/ Reseller/ DistributorBruker provides MALDI-TOF mass spectrometry systems for microbial identification in clinical microbiology laboratories.
  • Standard BiotoolsstandardChannel Partner/ Reseller/ DistributorStandard Biotools provides spatial biology solutions including GeoMX and CosMx platforms for spatial transcriptomics and proteomics analysis.
  • QiagenstandardChannel Partner/ Reseller/ DistributorQiagen provides sample and assay technologies for molecular diagnostics including automated extraction and PCR solutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Diagnóstica Longwood competitors and assessment

Company assessment

Direct peers

  • Palex Medical: Spain's largest medical technology and IVD distributor, headquartered in Barcelona with nationwide coverage. Direct competitor in Spanish molecular diagnostics distribution, addressing the same diagnostic and research laboratory customers with comparable multi-brand distribution models.
  • Master Diagnóstica: Spanish IVD manufacturer and distributor specializing in molecular biology and infectious disease diagnostics. A direct Spanish competitor operating in overlapping molecular diagnostic product categories.

Broad incumbents

  • Werfen: Iberian-headquartered IVD and medical device company with global reach, including the Izasa Scientific distribution arm. Both a partner of Diagnóstica Longwood and a broader incumbent competitor in Spanish IVD distribution, with significantly greater scale and product breadth.
  • bioMérieux: Global leader in microbiology diagnostics whose MALDI-TOF and molecular products are distributed by Diagnóstica Longwood in Spain. A broader incumbent competing across the same molecular and infectious disease diagnostic categories.
  • Roche Diagnostics: One of the largest IVD manufacturers globally, with deep penetration in Spanish hospital and reference laboratories. Represents both a potential partner and the principal disintermediation risk for distributors operating in molecular diagnostics.
  • Qiagen: Sample preparation and molecular diagnostics manufacturer whose products are distributed by Diagnóstica Longwood. A global incumbent in the same molecular biology workflow categories the company serves in Iberia.
  • Hologic: Molecular diagnostics manufacturer with strong presence in women's health, virology, and transplant monitoring. Overlaps with Diagnóstica Longwood's infectious disease and transplantation diagnostic product lines in Spain.
  • Cepheid (Danaher): Molecular diagnostics leader behind the GeneXpert platform. A direct competitive threat in molecular infectious disease diagnostics across Spanish hospital networks.
  • Abbott Diagnostics: Global IVD incumbent with broad molecular diagnostics and immunoassay offerings, widely distributed in Spanish reference laboratories. Competes with Diagnóstica Longwood for the same institutional customers.

Regional players

  • Sistemas Genómicos: Spanish genetics and molecular diagnostics laboratory services provider based in Valencia. Regional competitor in hereditary cancer, reproductive genetics, and NGS-based testing in Spain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Diagnóstica Longwood compliance and trust

Trust signal

Compliance2 records

Diagnóstica Longwood financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diagnóstica Longwood leadership team

Management profile

Number of profiles

Diagnóstica Longwood funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diagnóstica Longwood M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnóstica Longwood

What does Diagnóstica Longwood do?

Diagnóstica Longwood is a specialized distributor of in vitro diagnostic products and solutions for molecular biology. The company curates and distributes products from over 40 international manufacturers spanning NGS, qPCR, fragment analysis, spatial biology, and bioinformatics software. It provides expert scientific consultation, assay setup, protocol development, workflow optimization, and logistics services to clinical diagnostic and research laboratories in Spain and selected international markets.

Is Diagnóstica Longwood a public or private company?

Diagnóstica Longwood is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Diagnóstica Longwood founded?

Diagnóstica Longwood was founded in 1992. It employs 51 to 100 people.

Where is Diagnóstica Longwood based?

Diagnóstica Longwood is headquartered in Zaragoza, Spain, in the Europe region.

How does Diagnóstica Longwood make money?

One revenue line is on record: distribution of In Vitro Diagnostic Products.

Who are Diagnóstica Longwood's main competitors?

Direct peers on record are Palex Medical and Master Diagnóstica. Broad incumbents are Werfen, bioMérieux, Roche Diagnostics, Qiagen, Hologic, Cepheid (Danaher) and Abbott Diagnostics. Sistemas Genómicos is listed as a regional player.

Does Diagnóstica Longwood have an API?

No public API is recorded for Diagnóstica Longwood.

What industry is Diagnóstica Longwood in?

Diagnóstica Longwood's product category is In Vitro Diagnostics Distribution. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST). Its NAICS code is 325413 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales